Effect of Tegaserod on Orocecal Transit in Elderly Chronic Constipation Patients

Stopped early · Phase 4

Conditions studied: Chronic Constipation

In brief

This study will evaluate the effects of tegaserod on orocecal and colonic transit in patients over 65 years with chronic constipation.

Key facts

Study ID

NCT00348634

Run by

Novartis

People needed

60

Starts

2006-07-01

Expected to finish

2007-04-01

Last updated by the study team

2016-03-04

Who can join

Age: 65 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male \& Females aged 65 and older
• Patients must meet the criteria for chronic idiopathic constipation for at least 12 weeks
• Patients must have had a colonoscopy within the past 5 years
• Patients must pass a balloon expulsion test at screening
• Patients must be able to comply and understand the use of a diary

You may not qualify if…

• Patients with a clinically significant medical condition that would interfere with the patient completing the trial
• Patients with loose stools at least once per week
• Patients with IBS
• Known allergies to the same class of drug and/or allergies to eggs
• Patients who require the use of manual maneuvers to have a bowel movement
• Other protocol-defined inclusion/exclusion criteria may apply.

Where it is running

• Arkansas Gastroenterology, PA — North Little Rock, Arizona, United States
• University of Michigan Medical Center — Ann Arbor, Michigan, United States
• Temple University Hospital — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.